viral load

SHEN26 具有抗病毒活性，可用于治疗病毒感染的研究。

Netivudine 是一种有效的核苷类逆转录酶抑制剂(NRTIs)，是一种核苷类似物，具有抗水痘带状疱疹病毒活性，可用于治疗人类免疫缺陷病毒(HIV)感染。Netivudine 通过抑制逆转录酶起作用，通过抑制作用减少体内的病毒载量，减缓疾病的进展。

Zanamivir amine是一种抗病毒化合物，主要用于抑制流感病毒。作为神经氨酸酶抑制剂，它通过干扰病毒的复制过程，有效减少病毒载量，从而限制病毒的增殖。在临床上，Zanamivir amine常用于预防和治疗流感感染。

Ganglioside GM1 asialo is a component of cellular lipid rafts and can be formed by the cleavage of the sialic acid residue from ganglioside GM1 by neuraminidase. Ganglioside GM1 asialo is a glycolipid receptor for P. aeruginosa flagellin and stimulates defensive responses in host cells, including extracellular ATP release, calcium mobilization, and ERK1/2 phosphorylation when stimulated by flagellin and an anti-ganglioside GM1 asialo antibody. The percentage of ganglioside GM1 asialo-positive natural killer (NK) and CD8+ T cells in lung is increased in a mouse model of respiratory syncytial virus (RSV) infection compared with healthy animals. Depletion of ganglioside GM1 asialo-positive NK and T cells reduces IFN-γ levels in the lung, reduces weight loss, and increases lung viral load in RSV-infected mice. Ganglioside GM1 asialo mixture contains ganglioside GM1 asialo molecular species with C18:1 and C20:1 sphingoid backbones.

Remdesivir, also known as GS-5734, is a prodrug form of the antiviral nucleoside analog GS-44152. Remdesivir is a broad spectrum anti-viral drug that has shown to inhibit SARS-CoV-2, in vitro and in vivo. Efficacy of remdesivir against Ebola virus has been demonstrated. Remdesivir inhibits SARS-CoV-2 replication, reduces viral load, and exerts protective effects in SARS-CoV-2 infected animals. Remdesivir also reduces the pathological process, alleviates mild symptoms, and improves pulmonary lesions in SARS-CoV-2-infecetd animals. Remdesivir has been used as a compassionate drug for treating COVID-19 patients. *******WARNING****** Our product remdesivir is a pure chemical solid powder which is only for laboratory research use, NOT FOR HUMAN OR PATIENT USE

Casirivimab (REGN10933) 是一种人的单克隆抗体，靶向导致 COVID-19 的SARS-CoV-2病毒。Casirivimab 对 COVID-19 变种缺乏疗效。Casirivimab 可与Imdevimab 联合使用，有效降低病毒载量，改善病症。

Imdevimab (REGN10987) 是一种人的单克隆抗体，靶向导致 COVID-19 的SARS-CoV-2病毒。Imdevimab 对 COVID-19 变种缺乏疗效。Imdevimab 可与Casirivimab 联合使用，有效降低病毒载量，改善病症。

Suvizumab (KD-247) 是一种抗HIV-1的中和抗体。Suvizumab 有效中和了HIV-1MN、HIV-1SF2和HIV-189.6，IC50值分别为 0.1 µg mL、1.0 µg mL 和 0.2 µg mL。Suvizumab 减少了HIV 的病毒载量。Suvizumab 具有良好的耐受性，可用于预防HIV 感染。

Olgotrelvir 是一类小分子（SMOL）的丁型肝炎病毒（HCV）NS3 4A蛋白酶抑制剂。它特别针对丙型肝炎病毒复制过程中所需的关键酶，因而能有效抑制病毒的生命周期并减缓病变进程。通过选择性抑制此酶，Olgotrelvir 对丙型肝炎病毒展现出高度的抗病毒活性，为治疗丙型肝炎提供了一种潜在的药物选择。

ATV041是一种结合了布洛芬和核苷酸类似物的口服活性化合物。该化合物优化了口服药物动力学(PK)特性和组织分布，显示出对抗小鼠肝炎病毒(MHV)的能力。ATV041能够剂量依赖性地降低病毒载量，减少组织损伤并减轻病毒引发的炎症。

F9170是一种抗病毒肽，对应HIV-1包膜糖蛋白的789-803氨基酸。它与HIV-1包膜蛋白胞浆尾部的LLP1域结合，并抑制HIV-1 IIIB对MT-2细胞的感染(EC50 = 0.19 µM)。在恒河猴模型的类人猿免疫缺陷病毒(SHIV)感染中，F9170 (3 mg/kg)能降低血浆病毒负荷。